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Abstract
Veterans of Operation Desert Storm/Desert Shield – the 1991 Gulf War (GW) – are a unique 
population who returned from theater with multiple health complaints and disorders. Studies in the 
U.S. and elsewhere have consistently concluded that approximately 25–32% of this population 
suffers from a disorder characterized by symptoms that vary somewhat among individuals and 
include fatigue, headaches, cognitive dysfunction, musculoskeletal pain, and respiratory, 
gastrointestinal and dermatologic complaints. Gulf War illness (GWI) is the term used to describe 
this disorder. In addition, brain cancer occurs at increased rates in subgroups of GW veterans, as 
do neuropsychological and brain imaging abnormalities.
Chemical exposures have become the focus of etiologic GWI research because nervous system 
symptoms are prominent and many neurotoxicants were present in theater, including 
organophosphates (OPs), carbamates, and other pesticides; sarin/cyclosarin nerve agents, and 
pyridostigmine bromide (PB) medications used as prophylaxis against chemical warfare attacks. 
Psychiatric etiologies have been ruled out.
This paper reviews the recent literature on the health of 1991 GW veterans, focusing particularly 
on the central nervous system and on effects of toxicant exposures. In addition, it emphasizes 
research published since 2008, following on an exhaustive review that was published in that year 
that summarizes the prior literature (RACGWI, 2008).
We conclude that exposure to pesticides and/or to PB are causally associated with GWI and the 
neurological dysfunction in GW veterans. Exposure to sarin and cyclosarin and to oil well fire 
emissions are also associated with neurologically based health effects, though their contribution to 
development of the disorder known as GWI is less clear. Gene-environment interactions are likely 
to have contributed to development of GWI in deployed veterans. The health consequences of 
chemical exposures in the GW and other conflicts have been called “toxic wounds” by veterans. 
This type of injury requires further study and concentrated treatment research efforts that may also 
benefit other occupational groups with similar exposure-related illnesses.
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1. Introduction
The 1991 Gulf War (GW) was fought by a multinational coalition that formed to oppose 
Iraq’s invasion of Kuwait in 1990. The coalition included nearly 700,000 U.S. troops as well 
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as military personnel from the United Kingdom, Canada, Australia, and France, with over 30 
partnering countries. It began with a build-up of troops in the region (Operation Desert 
Shield) prior to the actual conflict (Operation Desert Storm), which included a six-week air 
campaign and four days of ground fighting before a ceasefire was declared on February 28, 
1991. This was followed by the return of the majority of the troops by the spring of 1991. 
There were few casualties on the winning side. The GW was remarkable for the numbers of 
chemical exposures experienced by troops, including the low-level chemical warfare agents 
released by the destruction of Iraqi facilities, extensive spraying and use of pesticides, 
medications given prophylactically to protect troops against hazardous exposures, and 
hundreds of oil well fires set by the Iraqi troops as they withdrew from Kuwait.
Within a year of return from the GW, it became apparent that troops were suffering from a 
variety of symptoms that were difficult to explain by health care providers, who did not 
recognize a typical medical illness in the veterans. Initially dubbed “GW syndrome” by the 
press, this disorder appeared to affect many, but not all, GW veterans. Fatigue, widespread 
pain, cognitive and memory problems, skin rashes, gastrointestinal and respiratory 
difficulties were commonly reported, but not every veteran afflicted by GW illness (GWI) 
presented with identical symptoms. Intensive research was initiated to characterize the 
disorder, understand its prevalence, investigate likely causes, and explore possible 
mechanisms of disease. Although the troops and some health care providers immediately 
suspected that chemical exposures were the cause of the condition, others ascribed GWI to 
post-traumatic stress disorder (PTSD) or other psychiatric conditions, or to the usual 
consequence of all wars. Effective treatments for GWI have been elusive but recently a 
treatment research effort has begun to flourish.
This paper explores the characteristics of GWI, its definition and prevalence (Epidemiology 
of GWI), the conditions in theater that may have caused GWI and specific indictors of 
nervous system dysfunction (Persistent Health Effects in GW Veterans in Relation to 
Deployment Experiences and Exposures), physiological mechanisms underlying GWI 
(Neuropathology of GWI) and experimental models of GWI and its causation (Animal 
Models of GWI Etiology and Pathology). It also summarizes current evidence related to a 
variety of neurological outcomes in addition to GWI that have been significantly associated 
with self-reported or modeled chemical exposures encountered by veterans during the GW. 
The paper is based on a recent summary of GWI research, Gulf War illness and the health of 
Gulf War veterans: Research update and recommendations, 2009–2013 (RACGWI, 2014), 
which our group authored. The paper and its tables focus on the literature appearing since 
2008, with occasional briefer summaries or tables on research published prior to 2008.
2. The epidemiology of GWI
2.1. Case definitions and prevalence
Research on GWI has relied on a number of differing definitions of the disorder, including 
chronic multisymptom illness (CMI, Fukuda et al., 1998), the Kansas GWI definition 
(Steele, 2000), the Haley syndrome criteria (Haley, Kurt, & Hom, 1997) and adaptations of 
these approaches. CMI has been used the most commonly in epidemiologic research to date. 
GW veterans who meet criteria for CMI must report one or more symptoms that have been 
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ongoing for at least six months in two of three categories, which include musculoskeletal 
pain (symptom list: joint pain, joint stiffness, muscle pain); mood-cognition (feeling 
depressed, feeling moody, feeling anxious, trouble sleeping, difficulty remembering or 
concentrating, trouble with word finding), and fatigue. CMI can be categorized as “severe” 
if the veteran rates each defining symptom as severe or “mild-moderate” for milder 
complaints. This case definition was recommended for clinical use by a recent IOM panel 
(IOM, 2014). The Kansas definition of GWI requires that cases have moderately severe or 
multiple chronic symptoms in at least three of six categories: fatigue/sleep problems, pain, 
neurological/cognitive/mood symptoms, respiratory complaints, gastrointestinal problems or 
skin symptoms (Steele, 2000). Veterans who have severe psychiatric disorders or other 
medical conditions that might predict similar symptoms are excluded. The 2014 IOM report 
on GWI case definitions recommended that this definition be used for research purposes 
(IOM, 2014). The Haley syndromes were originally developed using factor analytic 
evaluation of symptom data from a Seabees unit and include three symptom complexes. 
Syndrome 1 (Impaired cognition) is characterized by problems with attention, memory, and 
sleep along with depression. Syndrome 2 (Confusion/ataxia) involves problems with 
thinking and balance. Syndrome 3 (Neuropathic pain), is defined by joint and muscle pain.
Each of these definitions has particular strengths and weaknesses. The mild form of CMI is 
broad and overly inclusive, resulting in high prevalence rates even in control populations, 
though the severe form appears to be more specific to GWI (Nisenbaum, Barrett, Reyes, & 
Reeves, 2000). The Kansas criteria predict GWI at rates that appear to be consistent with 
those seen across multiple GW populations but can potentially exclude veterans with some 
concurrent medical disorders who may also have GWI. The Haley syndromes are quite 
narrow and underestimate the occurrence of the disorder but may allow highly specific 
characterization of veterans who meet criteria for a syndrome. When used in research, use of 
one of these definitions at least provides a basis for understanding the health characteristics 
of GWI cases being described. Many studies have not included any clear definition of how 
GWI was diagnosed among cases, a serious problem for the literature on this disorder. The 
ultimate goal of a consensus case definition for GWI has been advocated, which would lead 
to greater clarity in GWI research (RACGWI, 2014).
Because the individual symptoms seen in GWI can occur commonly in the general 
population, it is important to identify the excess rates of such symptoms in the GW veteran 
population, that is, the proportion of 1991 GW veterans who experienced multiple chronic 
symptoms over and above the “background” rate of these symptoms seen in contemporary 
veterans who did not deploy to the GW theater. Using the definitions of GWI described 
above, the 2008 RAC report compared the rates of the symptoms of the disorder in deployed 
GW veterans with those seen in control groups to provide a consistent methodology for 
estimating the prevalence of symptomatic illness attributable to GW service across studies.
Table 1 provides prevalence data from nine investigations that used this approach and three 
studies that provide estimates only for GW veterans. Seven of ten estimates indicated excess 
rates of symptomatology to be in the 25–32% range across multiple populations when using 
the more general case definitions for GWI (CMI, Kansas), while the more narrowly focused 
factor analytic case definitions such as the Haley criteria produced lower estimates of the 
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disorder. Longitudinal studies have consistently indicated that GWI rates and symptom 
frequencies reported by veterans have remained fairly constant, with no overall 
improvement over time (Hotopf et al., 2003; Ozakinci, Hallman, & Kipen, 2006; Proctor et 
al., 1998; Wolfe, Proctor, Erickson, & Hu, 2002).
2.2. Neurological conditions
Rates of neurological conditions that have been evaluated among deployed GW veterans 
compared to nondeployed controls include amyotrophic lateral sclerosis (ALS), brain 
cancer, seizures, neuritis and neuralgia, migraine headaches, multiple sclerosis (MS) and 
Parkinson’s disease (PD). The literature appearing on these disorders since 2008 is 
summarized in Table 2.
The neurological disorder that was first identified as occurring at increased rates in GW 
veterans was ALS. Prior to 2008, several studies had reported an excess rate of ALS among 
deployed GW veterans relative to nondeployed controls (Coffman, Horner, Grambow, & 
Lindquist, 2005; Horner et al., 2008). Some findings suggested that age of onset might be 
earlier in this population (Haley, 2003). However, Horner et al. (2008) reported that the 
increased rate of ALS in GW versus nondeployed veterans was maintained only for the first 
10 years after the war, peaking in 1996, suggesting a time-limited ALS “outbreak” in GW 
veterans (Horner et al., 2008). ALS risk was also reportedly related to specific locations of 
affected troops in theater (Miranda, Galeano, Tassone, Allen, & Horner, 2008). Two studies 
appearing since 2008 have examined the occurrence of ALS. One paper compared the 
characteristics of ALS in GW-deployed and era nondeployed veterans, concluding that age, 
site of onset and symptom presentation were similar in the two groups but that ventilator-
free survival time was shorter in the GW-deployed ALS patients (Kasarskis et al., 2009). A 
second study concluded that there was no excess mortality from ALS in deployed GW 
veterans compared to nondeployed era controls (Barth, Kang, Bullman, & Wallin, 2009).
Two studies have found excess rates of death due to brain cancers among GW veterans who 
were identified by Department of Defense (DoD) exposure models as having been possibly 
exposed to nerve gas agents during/following the demolition of the weapons depot in 
Khamisiyah, Iraq, in March of 1991 (Barth et al., 2009; Bullman, Mahan, Kang, & Page, 
2005). Veterans exposed to the highest levels of contaminants from oil well fires were also 
reported to have increased rates of brain cancer deaths (Barth et al., 2009).
The VA’s 2005 national longitudinal survey of nearly 9,000 GW era veterans published in 
2009 (Kang et al., 2009) found that deployed veterans reported being diagnosed with 
repeated seizures, neuralgia or neuritis, and stroke at greater rates than nondeployed era 
controls. Most of these conditions had also been reported at excess rates by GW veterans in 
VA’s 1996 national survey. Although these conditions were self-reported, medical record 
reviews for both the 1996 and 2005 VA national surveys indicated a high percent agreement 
(93–96%) between medical records and veteran-identified reasons for clinic visits and 
hospital stays (Kang et al., 2009; Kang, Mahan, Lee, Magee, & Murphy, 2000).
Increased rates of migraine headaches have been reported for some time among GW 
deployed veterans relative to controls (Gray, Reed, Kaiser, Smith, & Gastanaga, 2002; Kang 
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et al., 2000; Steele, 2000; Unwin et al., 1999). In GW veterans who met clinical criteria for 
chronic fatigue syndrome (CFS), 64% were diagnosed with migraine headaches, which is a 
rate similar to nonveteran subjects with CFS and significantly higher than that seen in 
sedentary controls (Rayhan, Ravindran, & Baraniuk, 2013).
There are no reliable data on incidence or prevalence of MS or PD among veterans of the 
1991 GW specifically. As noted in Table 2, a paper published in 2009 (Barth et al., 2009) 
concluded that GW veterans, overall, did not have higher mortality rates due to these 
disorders, compared to non-deployed era veterans. A study of MS in veterans who served in 
the military between 1990 and 2007 and had applied for disability compensation identified 
increased MS rates in women, African Americans, and Army veterans compared to other 
groups but did not focus specifically on deployed veterans of the 1991 GW (Wallin et al., 
2012). A later report indicated that rates of MS were not significantly different between GW 
veterans and nondeployed veterans in this convenience cohort (Wallin et al., 2014). Neither 
mortality data nor the number of veterans seeking disability benefits for MS provides a valid 
indication of whether GW veterans have been affected by excess rates of MS or most other 
neurological disorders since the war. Determining the impact of MS and other neurological 
disorders on GW veterans requires clear prevalence figures derived from well-designed 
research that utilizes population-based samples of GW veterans and appropriate comparison 
groups. It is also important to determine if rates of these disorders differ in GW veteran 
subgroups in connection with exposures or other deployment characteristics.
Reports summarizing the research on health problems in GW veterans have repeatedly 
emphasized that it is essential that studies intended to evaluate rates of illness and 
diagnosable diseases in GW veterans determine those rates in appropriate veteran 
subgroups, defined by particular exposures, locations in theater, or other relevant factors 
(RACGWI, 2008, 2014). It is now well understood that deployment exposures and 
experiences encountered by GW veterans were not uniform across theater. General analyses 
that combine all GW veterans into a single group will underestimate or completely obscure 
important findings associated with exposures that affected only a subgroup of veterans. This 
has been well illustrated, for example, by studies identifying excess rates of brain cancer 
mortality (Barth et al., 2009), brain structure and cognitive alterations (Chao, Abadjian, 
Hlavin, Meyerhoff, & Weiner, 2011; Heaton et al., 2007; Proctor, Heaton, Heeren, & White, 
2006) and respiratory disease (Cowan, Lange, Heller, Kirkpatrick, & DeBakey, 2002) 
among veteran subgroups who had the greatest exposure to nerve agents or oil fire smoke 
during the GW.
2.3. Psychiatric and psychological disorders
Deployment related stress, PTSD and other psychiatric conditions were extensively studied 
in GW veterans immediately after their complaints of increased ill health became known. 
Population-based studies indicated that rates of diagnosed PTSD in GW veterans were about 
3–6%, compared to a rate of 25–32% for GWI (RACGWI, 2008). When combat stressors, 
self-reported stress reactions and exposures to other stressful events in theater were 
quantified, these variables did not explain or predict diagnosis of GWI (RACGWI, 2008, p. 
78). The 2010 IOM report on GWI concluded: “The excess of unexplained medical 
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symptoms reported by deployed GW veterans cannot be reliably ascribed to any known 
psychiatric disorder” (IOM, 2010, p. 109).
Research studies investigating PTSD since 2008 are summarized in Table 3. These studies 
have concluded that PTSD symptom severity was associated with poorer physical health 
after deployment (Hassija, Jakupcak, Maguen, & Shipherd, 2012), that exposure to war 
casualties was associated with greater mental health decline (Gade & Wenger, 2011) and 
that combat exposure was related to PTSD, depressive symptoms and alcohol abuse (Hassija 
et al., 2012). Problem drinking in the GW population was found to be associated with PTSD, 
major depression and multisymptom illness (Coughlin, Kang, & Mahan, 2011). National 
Guard/Reservists and troops on active duty scored higher on PTSD rating scales and 
reported increased perceived threats and difficult living and working environments while 
deployed than comparison service men and women (Vogt, Samper, King, King, & Martin, 
2008).
The literature on neuroimaging and PTSD in deployed GW veterans mirrors PTSD findings 
in other veteran populations, including neuropathological and hormonal changes. GW 
veterans with PTSD were found in one study to have smaller hippocampal volumes on brain 
imaging than controls without PTSD (Apfel et al., 2011). Diminished hippocampal volume, 
metabolic activity changes and enhanced hormonal response to dexamethasone were 
reported in a second study of GW veterans diagnosed with PTSD (Yehuda et al., 2010). GW 
veterans diagnosed with combat-related PTSD showed smaller volume, area and thickness 
values in the hippocampal gyrus, superior temporal cortex, lateral orbital frontal cortex and 
pars orbitalis brain regions when compared to veterans without PTSD in a third investigation 
(Woodward, Schaer, Kaloupek, Cediel, & Eliez, 2009). Although these studies suggest that 
PTSD should be assessed and accounted for when evaluating neuroimaging outcomes in 
GW veterans, none of the reported studies controlled for potential nerve agents or other 
relevant environmental exposures that should also be assessed when evaluating magnetic 
resonance imaging (MRI) outcomes in this population.
Overall, research on PTSD and other psychiatric disorders among GW veterans shows lower 
rates of these conditions than are found in veterans of other wars and far lower than the 
prevalence of GWI. However, related physiology and predictors of PTSD occurrence and 
severity are similar.
3. Research on persistent health effects in GW veterans in relation to 
deployment experiences and exposures
Exposures in the GW theater that have been suspected of contributing to long-term health 
effects after the war include pesticides, depleted uranium munitions, airborne contaminants 
from the Kuwaiti oil well fires, chemical nerve agents, the anthrax vaccine and multiple 
vaccinations, widespread use of pyridostigmine bromide (PB) as a prophylactic measure 
against possible nerve agent exposure, chemical resistant coating (CARC) paint, and other 
hazards such as psychologically stressful conditions and heat. Military personnel commonly 
experienced multiple exposures in different combinations, for which possible interactive or 
synergistic effects have not been determined in human populations. One of the central 
White et al. Page 7
Cortex. Author manuscript; available in PMC 2016 January 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
challenges in evaluating risk factors for GW-related health outcomes involves a paucity of 
data on the types and doses of exposures experienced by veterans in theater. Initial research 
efforts on exposure–outcome relationships in this population were forced to rely on self-
report, which can be subject to bias. To address this concern, the U.S. DoD sponsored a 
number of intensive efforts to provide simulations, modeled estimates and detailed 
investigations in an effort to better characterize wartime exposures in different locations and 
military units. These include estimates of nerve agent exposures following demolitions at the 
massive munitions depot at Khamisiyah, Iraq, in March of 1991; modeled estimates of levels 
of airborne contaminants from the hundreds of Kuwaiti oil well fires; determinations of 
radiation and heavy metal exposures associated with depleted uranium munitions, and in-
depth investigations that provided detailed information on the use of pesticides and PB in 
theater. The hazards that have been studied most extensively with regard to health outcomes 
in this population include psychological stressors, pesticides, PB, sarin/cyclosarin, vaccines, 
depleted uranium and oil well fires.
Early exposure-related studies in the deployed GW veteran population were often 
problematic, due to analytic limitations that led to errors in interpretation of study findings. 
Such problems arose when studies that assessed myriad potential risk factors for GWI failed 
to control for confounding due to effects of concurrent exposures. Such studies typically 
reported that all, or most, GW experiences and exposures evaluated were significantly 
associated with GWI (RACGWI, 2008). In contrast, studies that evaluated individual GWI 
risk factors, while controlling for effects of other exposures, invariably identified a limited 
number of significant risk factors for GWI. Across all studies and populations, when 
confounding effects of concurrent exposures are considered, pesticide and PB use during the 
GW have been consistently identified as significant risk factors for GWI.
3.1. Pesticide exposures
As detailed elsewhere (DOD, 2001), GW personnel were often exposed to high levels of a 
variety of pesticides and insect repellants in theater. After adjusting for effects of concurrent 
exposures, significant associations between self-reported pesticide exposure and GWI, 
variously defined, have been identified in six of the seven different GW veteran populations 
in which they have been evaluated (RACGWI, 2008; Steele et al., 2012). Pesticide 
exposures were associated with GWI as defined by the Haley syndrome criteria in veterans 
from a single Navy unit (Haley & Kurt, 1997), CMI in Air Force veterans (Nisenbaum et al., 
2000), study-specific criteria among Navy Seabees (Gray et al., 2002), overall symptom 
severity among United Kingdom GW veterans (Cherry et al., 2001a, 2001b), and 
gastrointestinal and/or neuropsychological symptoms in Danish GW veterans (Ishoy, 
Suadicani, Guldager, Appleyard, & Gyntelberg, 1999; Ishoy, Suadicani, Guldager, 
Appleyard, Hein, et al., 1999; Suadicani, Ishoy, Guldager, Appleyard, & Gyntelberg, 1999). 
In a more recent study, Steele et al. (2012) also found an association between pesticide 
exposures and GWI for veterans who had served in different locations in theater. In addition, 
two studies have reported dose–response effects in the association between pesticide 
exposures and GWI (Cherry et al., 2001b; Haley & Kurt, 1997).
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3.2. PB
The 1991 GW is the only conflict in which PB was widely used by military personnel as a 
prophylactic measure intended to protect against effects of possible nerve gas attacks 
(Golomb, 1999). Self-reported PB use has also been consistently linked to ill health in GW 
veteran populations (see Table 4). Use of PB and/or experiencing side effects from PB were 
significantly associated with Haley syndrome symptomatology (Haley, Kurt, et al., 1997), 
with study-specific criteria for GWI among Navy Seabees (Gray et al., 2002), CMI in U.S. 
Air Force (Nisenbaum et al., 2000) and Army (Wolfe et al., 2002) veterans, a study-specific 
diagnosis of GWI in Oregon veterans (Spencer et al., 2001), and overall symptom severity in 
U.K. GW veterans (Cherry et al., 2001b). In a more recent study, PB use was associated 
with a significantly elevated risk for GWI (OR = 3.5) among GW veterans who were located 
in forward areas in theater (Steele et al., 2012). Overall, self-reported PB use has been 
identified as a significant risk factor for GWI in all seven populations in which it has been 
evaluated, after adjusting for the effects of other exposures. Three studies have reported 
dose–response effects for GWI in relation to PB use (Cherry et al., 2001b; Spencer et al., 
2001; Wolfe et al., 2002), and two have identified dose–response effects in relation to side 
effects from PB use (Cherry et al., 2001b; Haley & Kurt, 1997).
3.3. Chemical warfare agents
Several studies have linked sarin/cyclosarin exposure to central nervous system outcomes. 
The 2008 RAC report summarized studies from Boston investigators that examined the 
relationship between brain outcomes and DoD models of sarin/cyclosarin nerve gas agent 
exposures resulting from the demolition of the Khamisiyah, Iraq, weapons depot in March 
1991. This modeling provided a dose exposure estimate across three days as well as 
identification of U.S. troops who were likely in the area. Investigators found that reduced 
performance on neurobehavioral tests (Proctor et al., 2006) and smaller white matter 
volumes on brain imaging (Heaton et al., 2007) were associated with nerve gas agent 
exposure in a dose-dependent manner, with higher exposures predicting poorer performance 
and less overall brain white matter.
The findings of associations between DoD models of sarin/ cyclosarin exposure and MRI 
and behavioral outcomes have received support from recent investigations. In the first, gray 
matter and hippocampal volumes were found to be smaller in Khamisiyah-exposed veterans 
versus non-exposed veterans, and reduced white matter volume measured on a 1.5 T MRI 
was associated with poorer performance on neurobehavioral tests of executive and 
visuospatial functions (Chao, Rothlind, Cardenas, Meyerhoff, & Weiner, 2010). A second 
study from Chao et al. using a 4.0 T MRI and a different study sample found that total gray 
and total white matter volumes were both significantly reduced in Khamisiyah-exposed 
veterans, though findings were inconsistent regarding exposure-related cognitive differences 
(Chao et al., 2011). An additional study evaluating neurobehavioral outcomes found slower 
motor function speeds among Khamisiyah-exposed veterans compared to non-exposed 
(Toomey et al., 2009).
Two studies have reported significantly increased rates of death due to brain cancer among 
veterans who were located within the nerve agent plume area defined by DoD models of the 
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Khamisiyah demolitions. The earlier study, reporting on mortality through 2000, identified a 
nearly two-fold increase in brain cancer deaths in exposed veterans (Bullman et al., 2005). 
The observed increase was further supported by a 2009 VA study that evaluated mortality 
rates through 2004, which found a nearly three-fold increase in brain cancer deaths among 
veterans with the highest level of exposure to the Kuwaiti oil well fires and nerve agents 
associated with the Khamisiyah plume (Barth et al., 2009).
In a large national study, Haley et al. (2013) explored the relationship between chemical 
agent exposures and GWI. This group reported an increased risk for GWI defined as CMI or 
the Haley syndromes associated with hearing chemical alarms in theater, a proxy for 
possible nerve agent exposure. A significant dose–response effect in which veterans who 
reported hearing more alarms had greater risk for GWI was reported in this study. In 
contrast, this study reported no association between GWI and modeled exposure to the 
Khamisiyah plume, which contained these agents. A study of Kansas City-area GW veterans 
did not reveal associations between hearing chemical alarms and risk for GWI (Steele et al., 
2012).
In summary, the literature appearing prior to 2008 and since then clearly supports a link 
between adverse neurological outcomes and sarin/cyclosarin in populations of GW veterans 
with exposure to these agents. The link between such exposures and GWI remains unclear, 
perhaps because studies on the issue over time have assessed nerve gas agent exposure in 
different ways (self-report, chemical alarms, Khamisiyah models) and defined GWI 
differently.
Only limited evidence is available regarding exposures to and health effects of other 
chemical warfare agents known to have been present in theater. A study published in 2013 
tracked meteorological patterns in the region and indicated that U.S. troops may have been 
exposed to both nerve and blister agents as fallout from the Coalition bombing of chemical 
storage sites in 1991, during the early days of the air campaign (Tuite & Haley, 2013). This 
possibility had previously been raised by multiple sources, including Czech and other 
Coalition partners who reported chemical detections in northern Saudi Arabia in January of 
1991, with related evidence summarized in a 2004 report from the U.S. Government 
Accountability Office (U.S. Department of Defense Office of the Special Assistant for Gulf 
War Illnesses, 1998; U.S. General Accounting Office, 2004). Chemical detection monitors 
used during the war had limited capabilities for detecting mustard gas, but government 
reports have verified the presence of mustard gas at chemical manufacturing and storage 
sites in Iraq (U.S. Central Intelligence Agency, Persian Gulf War Illnesses Task Force, 
2002) and in munitions stored at the Khamisiyah weapons depot (U.S. Department of 
Defense Office of the Special Assistant for Gulf War Illnesses, 2002). A 2012 study 
described a mechanism by which mustard gas may have interacted with other exposures in 
theater in contributing to long-term health effects in GW veterans (Brimfield, 2012). 
However, there are no reports in the literature providing systematic evaluation of the effects 
of mustard gas on the health of GW veterans.
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3.4. Other exposures and chemical mixtures
Previous evidence that links GWI to individual vaccines and/or the total number of vaccines 
received by GW veterans is quite limited (Research Advisory Committee, 2008). Prior to 
2008, one study identified a significant association between GWI and the number of 
vaccines received after controlling for the effects of other exposures in theater (Cherry et al., 
2001b). A 2009 Australian study reported a weak association between health symptoms 
affecting GW veterans and the number of vaccines received, but no associations with 
vaccines reported in military records (Kelsall et al., 2009). Similarly, no associations 
between GWI and vaccines received in theater were reported in a 2012 study of Kansas 
City-area veterans (Steele et al., 2012). Some investigators have suggested that certain 
vaccines used during the GW contained squalene, which potentially gave rise to antibodies 
that might be associated with GWI (Asa, Cao, & Garry, 2000). However, a 2009 study 
found no association between diagnosis of CMI and the presence of squalene antibodies in 
Navy Seabees who served in the GW (Phillips et al., 2009).
Earlier studies provided mixed conclusions on the long-term health effects of exposures 
resulting from the hundreds of Kuwaiti oil well fires that burned between February and 
November, 1991, but close proximity to oil well fires was not ruled out as a risk factor for 
GWI (Research Advisory Committee, 2008). Two recent studies have provided additional 
evidence supporting long-term health effects in veteran subgroups that were most highly 
exposed to oil well fire smoke. A study of Kansas City-area GW veterans identified a 
significantly increased risk for GWI among GW veterans exposed to oil well fire smoke 
among personnel in forward areas in theater (Steele et al., 2012). Exposure to airborne 
pollutants from the Kuwaiti oil well fires has also been associated with increased risk for 
death due to brain cancer (Barth et al., 2009).
Multiple investigations have identified a high degree of overlap or clustering among GW 
exposures, indicating that personnel with some exposures (e.g., certain pesticides) were also 
much more likely to have additional exposures of concern (e.g., other pesticides, PB Boyd et 
al., 2003; Cherry et al., 2001b; Fricker et al., 2000; Steele et al., 2012). Most veterans 
experienced exposures to chemical mixtures in theater, and a large body of research using 
animal models has demonstrated persistent effects from combinations of GW exposures not 
seen with individual exposures. However, effects of these complex exposures have been 
minimally evaluated in GW veterans and remain unknown. Improved modeling of the 
contributions of individual and combined exposures would inform the assessment of mixed 
exposures as causes of GWI, as would the development of biomarkers of past exposures to 
specific chemicals of interest.
3.5. Genetic factors
Genetic vulnerabilities to chemicals present in theater likely played a role in the post-
deployment health of individual veterans (IOM, 2010; RACGWI, 2014). A recently 
published population study of 304 GW veterans identified a significant gene–exposure 
interaction in a subgroup of veterans with GWI. This study found that veterans with less 
active genetic variants of the butyrylcholinesterase enzyme were at substantially greater risk 
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for GWI if they used PB compared to veterans with these genotypes who did not use PB 
(Steele, Lockridge, Gerkovich, Cook, & Sastre, 2015).
4. Neuropathology of GWI
Because the most prominent symptoms of GWI are so clearly related to nervous system 
function and because GW veterans were exposed to several well-known neurotoxicants in 
theater, research has focused on the nervous system in attempts to identify the underlying 
neuropathological mechanisms of the disorder. Other systems, including the immune, 
respiratory, and gastrointestinal systems, have also received attention, though to a lesser 
extent. We will focus here on the known neuropathological and neurofunctional correlates of 
GWI, mentioning other systems when they are found on the pathway to nervous system 
effects.
4.1. Neuroimaging
Early research using MRI and electroencephalography (EEG) methods tended to compare ill 
and healthy GW veterans and to use insensitive clinical visual interpretation of images, 
finding few differences (Amato et al., 1997; Haley, Hom, et al., 1997; Lee, Bale, & Gabriel, 
2005; Levine et al., 2006; Newmark & Clayton, 1995). Since 2008, 16 additional peer-
reviewed EEG and neuroimaging papers have appeared, with more sophisticated 
methodology and closer attention to exposure–outcome relationships. Table 5 summarizes 
two papers that describe exposure-related neuroimaging findings in GW veterans. Table 6 
summarizes 13 additional studies that utilized imaging and EEG to characterize structural 
and functional alterations in relation to symptomatic illness in GW veterans.
Research prior to 2009 using magnetic resonance spectroscopy reported lower levels of 
several metabolites (choline, creatine, N-acetylaspartate [NAA]) using proton magnetic 
resonance spectroscopy (H-MRS) in the brainstems and basal ganglia in GW veterans who 
met Haley criteria for diagnosis of GWI (Haley et al., 2000) and lowered NAA/creatine 
ratios in basal ganglia (Meyerhoff, Lindgren, Hardin, Griffin, & Weiner, 2001) and 
hippocampus (Menon, Nasrallah, Reeves, & Ali, 2004). Research conducted by Weiner 
(2005) identified brain metabolic abnormalities in choline/creatine ratios in GW veterans 
meeting Haley Syndrome 2 (Confusion-ataxia) criteria for GWI (Weiner, 2005). However, a 
later study (Weiner et al., 2011) failed to confirm this finding: NAA, creatine and choline 
levels did not differ significantly in symptomatic versus asymptomatic GW veterans 
(Weiner et al., 2011). Rayhan, Raksit, et al. (2013), Rayhan, Ravindran, et al. (2013) and 
Rayhan, Stevens, et al. (2013) assessed lactate metabolite levels in the prefrontal cortex 
prior to and after an exercise challenge in ill GW veterans, finding that pre-exercise lactate 
level was associated with memory performance pre-and post-exercise. A single-photon 
emission computer tomography (SPECT) method that injects a radioactive tracer to produce 
a 3-D representation of metabolic activity in the brain was used to evaluate cerebral blood 
flow in 21 subjects diagnosed with Haley Syndrome 2 (Confusion-ataxia) compared to 17 
military controls; significantly lower cerebral blood flow in the caudate, globus pallidus, 
putamen and posterior hypothalamus was seen in the ill veterans (Haley et al., 2009).
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Because exposures experienced by GW veterans in theater included many chemicals that act 
on the cholinergic system (sarin, cyclosarin, organophosphates – OPs, PB; Golomb, 2008), 
one approach to imaging in this population employed physostigmine infusions to challenge 
the cholinergic system and evaluate the challenge effects. Table 6 summarizes three recent 
investigations utilizing physostigmine challenge. Using MRS probes, Li et al. (2011) 
detected abnormal cerebral blood flow through the hippocampus before the physostigmine 
challenge, and after the challenge veterans with Haley Syndromes 2 (Confusion-ataxia) and 
3 (Neuropathic pain) showed significantly abnormal increases in regional cerebral blood 
flow in the hippocampus of both hemispheres. A second physostigmine challenge study 
failed to find any decrease in brain activity in symptomatic GW veterans; instead, GWI 
patients showed either no change or increased cerebral blood flow after physostigmine 
injection, with changes being statistically significantly different from sedentary control 
veterans. Differences were most significant in the hippocampus, amygdala, caudate and 
thalamic areas after physostigmine injection (Liu et al., 2011). Similar elevated cerebral 
blood flow results with physostigmine challenge were also reported in a study using SPECT 
methodology (Haley et al., 2009).
Reduced white and gray matter volumes in cortical areas have been consistently reported in 
structural MRI studies of ill GW veterans (Chao et al., 2011, 2010; Rayhan, Stevens, et al., 
2013; Rosenzweig, Bodi, & Nashef, 2012). Reduced signaling was also seen in the 
thalamus, caudate, hippocampus, globus pallidus and putamen (Calley et al., 2010; Haley et 
al., 2009; Li et al., 2011). As noted above and in Table 6, Chao et al. (2011) found that GWI 
and CMI diagnoses significantly predicted volume changes in sarin and cyclosarin-exposed 
subjects.
Several studies have used functional MRI (fMRI) to assess functional anomalies and white 
matter integrity using diffusion tensor imaging (DTI). For example, Rayhan, Raksit, et al. 
(2013), Rayhan, Ravindran, et al. (2013) and Rayhan, Stevens, et al. (2013) reported that 
fatigue, pain and hyperalgesia were associated with diminished white matter integrity in GW 
veterans with CMI or CFS (Rayhan, Stevens, et al., 2013). Axial diffusivity in the right 
inferior fronto-occipital fasciculus specifically predicted CMI diagnosis in this study. In 
addition, civilian controls and ill GW veterans exposed to exercise revealed two distinct 
GWI phenotypes. One subgroup displayed orthostatic tachycardia while the other developed 
hyperalgesia. Imaging results on both groups showed signs of brain atrophy when compared 
to controls and altered working memory compensation in brain areas that were different 
from controls. In a second study, fMRI scanning of 53 symptomatic GW veterans showed 
significant signal changes in the thalamic and caudate regions in Haley Syndrome 2 
(Confusion-ataxia) subjects when compared to other symptomatic veterans and healthy 
controls. Furthermore, the Haley Syndrome 2 group’s performance on a semantic learning 
task was associated with signal change in the caudate areas bilaterally (Calley et al., 2010).
Responses to an innocuous heat stimulus in symptomatic and control GW veterans was 
investigated using fMRI methodology in a study by Gopinath et al. (2012). Compared to 
Haley Syndrome 3 (Neuropathic pain) patients and controls, patients with Haley Syndromes 
1 (Impaired cognition) and 2 (Confusion-ataxia) showed significantly reduced brain activity 
in the insula, somatosensory areas S1 and S2, the medial prefrontal cortex, supplementary 
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motor area, premotor cortex and dorsolateral prefrontal cortex. An investigation using a 
working memory challenge task during fMRI concluded that symptomatic GW veterans 
showed distinctive prefrontal cortical activity when compared to civilian controls consistent 
with impairments in central executive processing (Hubbard et al., 2013).
Using an EEG task that measures hyperarousability, (Tillman et al., 2012) significant 
associations were found between P1 latency and amplitude in veterans with Haley 
Syndrome diagnoses 2 (Confusion-ataxia) and 3 (Neuropathic pain) when compared to 
healthy controls and Haley Syndrome 1 (Impaired cognition) subjects. GW veterans with 
Syndromes 1 and 2 showed P3a amplitudes that were significantly different from controls 
and Syndrome 3 subjects. In a follow-up study, significantly lower P3b amplitudes were 
seen in all three syndrome groups when compared to controls (Tillman et al., 2013).
As a group, studies that utilize imaging and EEG probes when investigating veterans with 
GWI defined in various ways and when assessing GW veterans with sarin/cyclosarin 
exposure consistently identify structural and electrical abnormalities in the central nervous 
system: 14 of the 15 papers published since 2008 and summarized in Tables 5 and 6 support 
this conclusion.
4.2. Neurocognition
GWI symptoms commonly include complaints about memory and concentration as well as 
dysregulated mood. These symptoms have been systematically investigated in this 
population through neuropsychological assessments in order to provide objective, quantified 
and standardized measurements of specific brain and behavioral functions. Early research 
comparing deployed GW veterans and nondeployed era veterans found that affective and 
mood complaints often differentiated the two groups, with greater dysphoria among the 
deployed veterans. However, overall comparisons between deployed and nondeployed era 
veterans generally failed to reveal cognitive differences in the two groups. Significant 
differences tended to emerge only in research that compared deployed veterans with and 
without GWI and that compared veterans who experienced specific exposures in theater to 
deployed veterans who did not experience these exposures.
Several investigations published prior to 2009 concluded that visuospatial and motor skills 
were poorer and greater dysphoria was evident in deployed veterans with GWI compared to 
healthy GW veterans (Anger et al., 1999; Axelrod & Milner, 1997; Binder et al., 1999; 
Bunegin, Mitzel, Miller, Gelineau, & Tolstykh, 2001; Lange, Van Niekerk, & Meyer, 2001; 
Storzbach et al., 2000; Storzbach, Rohlman, Anger, Binder, & Campbell, 2001; Sullivan et 
al., 2003). A subgroup of GW veterans who were markedly slower on psychomotor tasks 
was identified in one study, suggesting that there may be subgroups within the GWI 
population who are markedly impaired (Anger et al., 1999; Storzbach et al., 2001). Self-
reported exposure to PB was found to be associated with poorer performance on tests 
assessing executive function and with greater mood complaints (Sullivan et al., 2003; White 
et al., 2001). Self-reported exposure to chemical and biological warfare agents predicted 
greater difficulty on neuropsychological tests that assess memory and attention as well as 
poorer affective function among deployed veterans (White et al., 2001). And modeled sarin 
and cyclosarin exposure experienced by GW veterans in relation to the Khamisiyah 
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demolition was associated with poorer performance on tests of psychomotor speed and 
visuospatial skills (Proctor et al., 2006).
Table 7 lists four neuropsychological assessment studies published since 2008. Toomey et 
al. (2009) identified differences between deployed and nondeployed veterans in a large 
study (N = 1061 deployed, N = 1128 nondeployed), with deployed veterans showing slower 
motor speed and worse attention. Also noted in this study was poorer performance on 
neuropsychological tests within certain domains that was associated with specific self-
reported exposures. Sustained attention was poorer in veterans with self-reported exposure 
to contaminated food and water, verbal memory performance was worse among veterans 
who reported being at Khamisiyah (and presumably exposed to sarin/cyclosarin), visual 
memory was poorer in veterans with self-reported CARC paint exposure, and motor speed 
was slower among veterans who reported being near SCUD missiles (Toomey et al., 2009). 
As already summarized, Chao et al. found relationships between modeled exposure to nerve 
gas agents from the Khamisiyah demolition and cognition in one study that was related to 
volumetric MRI measures (Chao et al., 2010) but cognitive findings from a second 
investigation were inconsistent (Chao et al., 2011; see Table 6). A small investigation that 
assessed 25 deployed and 16 nondeployed veterans reported no differences in cognitive 
outcomes, but measures assessing quality of life and mood did differentiate the two groups 
(Wallin et al., 2009). This study must be viewed with caution given low power to detect 
differences between groups. In another study, a GO-NOGO task was administered while 
veterans with self-reported cognitive problems underwent EEG and results were compared 
to control GW veterans; the veterans with cognitive complaints were less able to inhibit 
inappropriate responses than the controls (Tillman et al., 2010). A face-name paradigm was 
used by Odegard et al. (2013) to compare performance among GW veterans with the Haley 
syndromes and healthy controls. Haley Syndrome 3 (Neuropathic pain) veterans performed 
worse than those with Haley Syndrome 1 (Impaired cognition) and healthy controls.
4.3. Autonomic nervous system (ANS)
ANS dysregulation in GW veterans was noted in several early studies reviewed in the 2008 
RAC report. Findings included significant differences between symptomatic and healthy 
veterans in relation to 24-h heart rate variability (HRV; Haley et al., 2004; Stein et al., 
2004), increased HRV in symptomatic veterans after exposure to diesel vapors (Fiedler et 
al., 2004), differential blood pressure, heart rate, and symptomatic responses with tilt table 
testing (Clauw, 2001; Davis, Kator, Wonnett, Pappas, & Sall, 2000; Lucas, Armenian, 
Debusk, Calkins, & Rowe, 2005; Sastre & Cook, 2004) and blunted blood pressure response 
to cognitive stressors (Peckerman et al., 2003, 2000). No statistical differences were 
identified in tests of sympathetic skin response and airway pressure response (Sharief et al., 
2002).
A more recent study identified several significant ANS differences between GW veterans 
meeting criteria for the three Haley syndromes and controls. GW veterans meeting any of 
the three syndrome criteria scored worse than controls on the Autonomic Symptom Profile 
questionnaire, due to higher self-reports of gastrointestinal distress, sleep and urinary 
dysfunction and orthostatic intolerance. They also received higher Composite Autonomic 
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Severity scores, and Syndrome 2 (Confusion-ataxia) veterans showed significantly reduced 
sweat response. This study also found diminished night-time HRV in all three syndrome 
groups (Haley et al., 2013).
4.4. Neuroendocrine function
Although clinical neuroendocrine disorders have not typically been observed in GW 
veterans, a series of studies conducted by Golier and colleagues investigated hypothalamic-
pituitary-adrenal (HPA) axis parameters in GW veterans for over a decade. This work 
revealed that cortisol suppression in response to dexamethasone was significantly related to 
musculoskeletal symptoms and was more pronounced in GW veterans reporting PB use 
(Golier, Legge, & Yehuda, 2006; Golier, Schmeidler, Legge, & Yehuda, 2006). In addition, 
this line of research consistently revealed patterns of HPA-axis functioning in GW veterans 
that are distinct from those seen in other conditions, including depression, PTSD and CFS 
(Golier, Caramanica, & Yehuda, 2012; Golier, Schmeidler, Legge, & Yehuda, 2007; Golier, 
Schmeidler, & Yehuda, 2009). Preliminary findings relevant to other hypothalamic–pituitary 
parameters were recently reported by clinical investigators in the U.K., who identified a 
variety of abnormalities in blood hormone levels, most prominently gonadotropin releasing 
hormone, in a small series of symptomatic GW veterans (Wakil, Sathyapalan, & Atkin, 
2011).
4.5. Mitochondrial dysfunction
Some GW-related exposures, such as organophosphates (OPs), can be toxic to mitochondria, 
producing symptoms such as fatigue and brain, muscle, gastrointestinal (GI), sleep and 
autonomic dysfunction, all symptoms that are seen in GWI (Odegard et al., 2013). 
Phosphocreatine is a back-up energy source for muscle that is depleted during exercise, and 
the speed of recovery is dependent on the rate of mitochondrial ATP synthesis. Post-exercise 
phosphocreatine recovery rate (PCr-R) assessed using 31-phosphorus magnetic resonance 
spectroscopy has been confirmed as a robust measure of mitochondrial defects in vivo 
(Thompson, Kemp, Sanderson, & Radda, 1995). A case–control study compared PCr-R in 
veterans with GWI and in age-, sex- and ethnicity-matched controls. A significant PCr-
prolongation indicating delayed recovery was seen in the veterans with GWI, supporting the 
study hypothesis that mitochondrial dysfunction is a mechanism of GWI (Koslik, Hamilton, 
& Golomb, 2014).
5. Animal models of GWI etiology and pathology
Animal studies have identified biological effects of GW exposures and combinations of 
exposures that were previously unknown. The evidence concerning these effects has 
burgeoned since 2008, with new animal models of GWI evaluating persistent and delayed 
effects of exposures in theater. It is axiomatic that animals are not humans and conclusions 
from animal studies must be used as clues that can be further investigated in appropriate 
human research. However, the outcomes from animal studies are important because data on 
exposure–outcome relationships can be collected rapidly and efficiently to provide 
mechanistic insights.
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Animal models have been used to characterize the effects of pesticides, PB, insect 
repellants, nerve agents and stress, either administered alone or in combination. Multiple 
studies published prior to 2008 established that neurobiological effects of low-dose sarin 
exposure resulted in delayed and persistent effects in animals (Henderson et al., 2002; 
RACGWI, 2008). Early animal models of PB established that this drug can adversely affect 
nerve function (Drake-Baumann & Seil, 1999; Hudson, Foster, & Kahng, 1985) and can also 
have gastrointestinal (Kluwe, Page, Toft, Ridder, & Chung, 1990), muscular (Adler, 
Deshpande, Foster, Maxwell, & Albuquerque, 1992), immune (Peden-Adams et al., 2004) 
and cardiovascular (Bernatova, Babal, Grubbs, & Morris, 2006) effects. Rodents given PB 
over time showed a number of locomotor, learning and behavioral deficits (Abou-Donia, 
Dechkovskaia, Goldstein, Bullman, & Khan, 2002; Abou-Donia et al., 2001; van Haaren et 
al., 2001), despite showing no overt signs of cholinergic toxicity or illness. Three studies in 
rodent models found that the adverse effects of PB were enhanced by stressors (Abdel-
Rahman, Abou-Donia, El-Masry, Shetty, & Abou-Donia, 2004; Abdel-Rahman, Shetty, & 
Abou-Donia, 2002; Friedman et al., 1996). Other studies showed reduced levels of 
acetylcholin-esterase (AChE) in the brains of animals given PB and exposed to stressors 
(Baireddy, Mirajkar, Nallapaneni, Singleton, & Pope, 2007; Sinton, Fitch, Petty, & Haley, 
2000). PB administered with the nerve agent sarin produced locomotor deficits (Abou-Donia 
et al., 2002; Scremin et al., 2003), EEG abnormalities (van Helden et al., 2004), changes in 
HRV (Scremin et al., 2003) and increased markers of oxidative stress in urine (Shih, Hulet, 
& McDonough, 2006).
Since 2008, a large number of animal studies have built on earlier findings, further 
elaborating relationships between GW theater exposures and the symptoms of GWI. This 
work is summarized in Table 8. It has focused on behavior, cognition, neurotransmission 
and intracellular signaling; molecular and cellular disruptions of axonal transport, and 
genomic and proteomic profiling to identify previously unknown targets of GW exposures.
5.1. Altered behavior, cognitive function, neurotransmission and intracellular signaling
OPs have been shown to inhibit the enzyme AChE and can covalently bind 
organophosphorylate serine residues throughout the body. Mice exposed to low doses of PB, 
a carbamate medication that is also an AChE inhibitor, and permethrin (PER; a pyrethroid-
based pesticide) showed elevated levels of the reservoir compounds necessary for 
acetylcholine synthesis (Abdullah et al., 2013). Ten days of chlorpyrifos (CPF) exposure in 
combination with PB and PER increased basal acetylcholine levels in the brains of six-
month old mice. Within the dentate gyrus, exposed mice had reduced immunostaining for a 
marker of immature neuronal cells and a synaptic vesicle protein (Ojo et al., 2013). In 
addition, there was an increase in astrogliosis within the prefrontal cortex and a reduction in 
several vascular injury markers within the whole brain homogenates in exposed mice 
compared to controls. Animal models also showed impairments in spatial navigation and 
memory after GWI-related exposures (Parihar, Hattiangady, Shuai, & Shetty, 2013). 
Combined stress and pesticide exposure chronically over four weeks produced significant 
increases in glial-related inflammation, reduced neuronal growth in the hippocampus and 
reduced overall hippocampal volume at testing two months post-exposure (Parihar et al., 
2013).
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Hippocampal synaptic transmission and reduced neuronal spine density were observed at 
three months post CPF exposure by Speed et al. (2012). These data support the hypothesis 
that acute exposures to CPF at low dosages can produce long lasting changes to brain areas 
involved in cognition without producing obvious signs of cholinergic toxicity. Exposure to 
CPF, PER and PB produced changes in K+ channel kinetics and excitability in muscle pain 
receptors, even though no behavioral changes were seen (Nutter, Jiang, & Cooper, 2013). 
Exposure of mice to PB and DEET for two weeks followed by exposure to the sarin 
surrogate, diisopropylfluorophosphate (DFP), or exposure to one week of CPF, resulted in 
deficits in signaling through glutamatergic receptors in the striatum (Torres-Altoro et al., 
2011). Exposure of mice to DFP also results in neuroinflammation in multiple brain areas, 
effects which are markedly exacerbated by prior exposure to corti-costerone as a stressor 
surrogate (O’Callaghan, Kelly, Locker, Miller, & Lasley, 2015). Taken together, evidence 
from animal studies suggests that subtle brain changes at the neuronal signaling and 
structural levels could underlie some of the symptoms experienced by GW veterans. Month-
long exposures to permethrin, PB and DEET with and without a brief exposure to restraint 
stress produced mood and cognitive changes in animal models and was consistent with 
neuro-inflammatory changes in hippocampal brain areas (Parihar et al., 2013).
OPs have been shown to disrupt multiple functions beyond those linked strictly to AChE. 
While AChE inhibition from exposures that occurred in the GW (e.g., sarin and CPF) have 
been implicated in the etiology of GWI (Golomb, 2008), other studies have identified 
additional secondary pathways of OP effects apparently unrelated to inhibition of AChE (see 
review; Terry, 2012). A notable non-cholinergic target of OPs is the process of axonal 
transport, a key nervous system function for transporting molecules (e.g., RNA and proteins) 
and subcellular organelles (e.g., mitochondria and synaptic vesicles) through the cytoplasm 
of axons (Terry, 2012). OPs can affect axonal transport directly through altering microtubule 
structure by binding to tubulin required for transport function (Grigoryan et al., 2008). This 
and similar covalent interaction of OPs with proteins to alter their function is not limited to 
binding to serine residues, because tyrosine is also bound by OP esters (Grigoryan et al., 
2009), suggesting effects on energy metabolic/mitochondrial function at dosages too low to 
inhibit AChE. The direct consequences of OP binding (e.g., CPF) on transport has been 
visualized in vitro and shown to affect movement of mitochondria within the axon at 
concentrations below those that inhibit AChE (Middlemore-Risher, Adam, Lambert, & 
Terry, 2011). Effects of OPs on axonal transport were accompanied by changes in behavior 
associated with impairments in attention, memory and other aspects of cognition after 
exposure of rats to the OP CPF and the sarin surrogate DFP (Terry, 2012). Thus, axonal 
transport disruption by OPs relevant to exposures in the 1991 GW can result in deficits in 
cognition in animal models that resemble symptoms in ill veterans. As with most animal 
models of GWI studied to date, future evaluations of GW exposures on axonal transport 
would benefit from combined exposures at low levels. Nevertheless, studies that have been 
conducted since 2008 clearly indicate that low levels of OPs can adversely affect a key CNS 
process that may serve as a partial mechanistic explanation for symptoms associated with 
GWI.
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Chronic exposures to PB and PER and to PB, PER, DEET and restraint stress to recapitulate 
exposures that occurred in the GW were applied in a in a mouse model by Abdullah and 
colleagues (Abdullah et al., 2011, 2012, 2013). Results revealed novel effect domains. 
Phospholipids key to lipid metabolism, axonal transport and endocrine and immune function 
were implicated. These effects were accompanied by behavioral findings indicating sensory, 
motor and memory impairments as well as subtle effects on glial morphology suggestive of 
underlying neuropathology and/or neuroimmune alterations. Together these data show the 
value of obtaining a broader perspective of the effect domains associated with exposure to 
GW-related agents. These studies serve as a template to discover additional pathways and 
systems disrupted by GW-related exposures.
In summary, animal models of GW-relevant exposures to individual chemicals, chemical 
mixtures, and chemicals plus other stressors have demonstrated alterations in nervous 
system outcomes (behavior, cognition, neurotransmission, intracellular signaling, molecular 
and cellular disruptions of axonal transport); liver and cardiovascular function; genomic, 
proteomic, lipidomic and metabolomic profiles, and mitochondrial changes. These studies 
have confirmed hypotheses that exposures are important in the development and expression 
of GWI symptomatology, that health effects due to exposures and exposure mixtures are 
often delayed and that persistent effects can be seen long after exposure has ended.
6. Conclusions/discussion
6.1. Prevalence and case definitions of GWI and other disorders affecting GW veterans
The disorder known as GWI has been investigated systematically since the early 1990’s. 
Prevalence has been most validly characterized as the excess of diagnostic indicators of the 
disorder in deployed GW veterans relative to veterans who served during the same period 
but did not deploy to the GW. The two most commonly used case definitions are CMI 
(Fukuda et al., 1998) and the Kansas definition (Steele, 2000). Using these two definitions, 
prevalence of GWI is estimated to be about 25–32% in deployed GW veterans (RACGWI, 
2008, 2014). Application of the more narrowly defined Haley criteria (Haley, Kurt, et al., 
1997) tends to result in much lower prevalence estimates for GWI. Although these 
definitions have frequently been characterized as “symptom-based” and not related to 
known medical diagnoses, GWI symptoms are consistent with those seen in chemically 
induced toxic injuries and residual encephalopathies (Baker et al, 1985) and are associated 
with a range of objectively-measured biological alterations. Prognosis for recovery is 
understudied but appears to be poor.
Neurological disorders also occur in GW veterans. They may occur in connection with GWI 
(e.g., migraine headaches, neuritis or neuralgia) or as separate disorders, possibly occurring 
on a continuum with GWI. ALS, stroke, brain cancer and seizures have been identified at 
excess rates in deployed GW veterans, and brain cancer has been related to specific 
chemical exposures in theater. Given the presence of white matter anomalies in some 
subgroups of GW veterans, there has been concern that MS might also occur at higher rates 
in this population. However, the data required to draw valid conclusions about MS have not 
been systematically collected or analyzed. Because PD is also sometimes seen in patient 
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groups with chemical exposures, this disorder also remains a condition of concern; the status 
of knowledge about GW deployment-related PD is similar to that of MS.
Studies evaluating psychiatric disorders among deployed GW veterans have consistently 
shown that combat and other psychological stressors are associated with PTSD, anxiety, 
depression and alcohol abuse. However, psychological stressors are not significant 
predictors of GWI diagnosis and PTSD occurs at much lower rates in the deployed GW 
population than GWI. While some patients with GWI report dysphoria and sleep problems, 
these may reflect neuropathological effects of GW exposures (organic affective symptoms) 
and/or the consequences of being chronically ill with a debilitating condition for many 
years.
6.2. Etiology of GWI and neurological dysfunction
Across all studies and populations and since the earliest findings appeared linking self-
reported exposures to diagnosis of GWI, two types of theater-related exposures have been 
consistently identified as risk factors for the disorder: exposures to pesticides and PB use. In 
research controlling for concurrent exposures, pesticide exposures were significantly 
associated with GWI in six of seven GW populations evaluated, and PB exposure was 
significantly associated in all seven of the populations studied. In addition, research that 
assessed the relationship between degree of exposure to pesticides and PB has consistently 
identified significant positive dose–effect relationships between degree of exposure and 
likelihood of GWI diagnosis (greater exposure is associated with higher likelihood of GWI 
diagnosis). Further evidence on the long-term residual effects of pesticides and PB carried 
out many years after the war using neurocognitive and neuroendocrine assays suggests 
significant sequelae of these exposures: neurocognitive research has shown that higher 
exposures to PB and pesticides are associated with decrements in cognitive function and 
they are also associated with alterations in HPA parameters in investigations of 
neuroendocrine function. Multiple studies using animal models of PB and pesticide 
exposure (individually and in combination with other exposures) have identified persistent 
and delayed structural changes in the brain and CNS as well as neurobehavioral dysfunction 
that are consistent with the symptomatology associated with GWI. And the profiles of 
symptoms and decrements in neurocognitive function identified in GW veterans parallel 
those seen in dozens of studies of occupational groups exposed to pesticides and pesticide 
mixtures. Taken together, these multiple lines of evidence suggest that exposure to 
pesticides and PB use are causally associated with GWI and other neurological 
consequences in GW veterans.
Research evaluating the relationship between exposure to the nerve agents sarin and 
cyclosarin and ill health in deployed veterans has consistently shown that modeled exposure 
to these agents is associated with structural brain differences on MRI (especially total white 
and grey matter volumes), with neurocognitive outcomes and with mortality due to brain 
cancer. The limited evidence on the relationships between these exposures and diagnosis of 
GWI has been inconsistent and inconclusive. More research on these exposures is needed to 
determine if they are causative for GWI.
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Exposure to oil well fire smoke has also been less well studied and may be linked to GWI, 
respiratory disorders and brain cancer mortality, but more research is needed to make 
conclusions. The research to date on vaccines is also limited, with inadequate evidence to 
persuasively support a link between GWI and specific types of vaccines or the number of 
vaccines received.
6.3. Pathobiology of GWI and neurological and neuroimmune function in GW veterans
Because GWI is a multi-system illness, human studies on pathobiology have been difficult 
to pursue, particularly with regard to basic underlying mechanisms that may induce multiple 
symptoms and types of dysfunction. There is clear neurological pathology in this population. 
Studies of veterans with GWI defined in various ways and in veterans exposed to nerve gas 
agents that utilize varying imaging and EEG probes consistently identify structural and 
electrical abnormalities in the central nervous system: 14 of the 15 papers published since 
2008 support this conclusion, as does a sizable literature published earlier. Similarly, 
neurocognitive research on GW veterans has consistently revealed exposure-related 
dysfunction among deployed GW veterans and differences between ill and healthy GW 
veterans suggestive of structural and functional CNS pathology.
Some GWI symptoms imply ANS involvement and early research consistently suggested 
that ANS dysfunction was prominent in GWI. This has been less well studied recently, but 
remains a likely contributing factor in the pathobiology of the disorder.
Neuroendocrine and immune dysregulation have also been reported in a number of studies, 
including those using protocols that demonstrate pronounced differences after exercise and 
other challenges. Specific patterns of altered HPA-axis functioning that are quite distinct 
from other conditions, including PTSD, have been reported in a long line of research. And 
one recent study has provided evidence of significant mitochondrial dysfunction in veterans 
with GWI. Further studies are warranted to determine the exact nature of identified 
alterations, which may lead to treatment options.
6.4. Animal models of GWI and theater exposures
Research on animal models of GW exposures and of GWI has contributed a great deal to our 
understanding of the exposure–outcome relationships and underlying mechanisms of GWI 
and other health issues in deployed GW veterans. These studies have examined the acute, 
chronic, and lasting residual effects of single and mixed exposures to PB, OPs, permethrin, 
DEET, nerve gas agents and experimental stressors on CNS outcomes. Results have shown 
both delayed and persistent effects (including effects seen an extended time after exposure 
has ended) on behavior, cognition, neurotransmission, intracellular signaling, and molecular 
and cellular transport in the CNS as well as liver and cardiovascular function, mitochondrial 
function, and genomic, proteomic, lipidomic and metabolomic profiles. Genomic and 
proteomic surveys have implicated phospholipids essential to lipid metabolism, axonal 
transport and endocrine and immune function. These effects were seen in the context of 
sensory, motor and memory impairments and changes in glial morphology. Taken together, 
the animal research supports the plausibility of the occurrence of multi-system health 
complaints existing long after exposure as well as underlying neuropathological and 
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neuroimmune mechanisms of GWI and other disorders and dysfunctions in exposed GW 
veterans.
6.5. The bottom line
The research data to date on health in GW veterans converge to support these conclusions:
• Between one-fourth and one-third of deployed GW veterans are affected by a 
disorder characterized by chronic symptoms involving multiple body systems; this 
condition is best identified by the term GWI.
• This disorder was caused by toxicant exposures, individually or in combination, 
that occurred in the GW theater. At present, research most clearly and consistently 
links pesticide and PB exposures to GWI, while exposures to low-level nerve gas 
agents, contaminants from oil well fires, multiple vaccinations, and combinations 
of these exposures cannot be ruled out.
• In addition to GWI, deployed GW veterans suffer from a variety of neurological 
disorders, alone or in combination with GWI. ALS, brain cancer, stroke, migraine 
headaches, neuritis and neuralgia have all been reported as occurring at higher rates 
in this population. Rates of disorders such as MS and PD are unknown and further 
intensive research is needed to determine whether they are elevated in GW 
veterans. This should include studies focused on GW veteran subgroups classified 
by individual exposures or geographic locations in theater.
• Neurological disorders as well as alterations in brain structure and function have 
been linked to specific exposures in theater, including nerve gas agents, PB and oil 
well fires
• The state of knowledge on the health of deployed GW veterans supports the 
conclusion that they are suffering from persistent pathology due to chemical 
intoxication (sometimes referred to by veterans as “toxic wounds”).
• Further research into the mechanisms and etiology of the health problems of GW 
veterans is critical to developing biomarkers of exposure and illness and preventing 
similar problems for military personnel in future deployments; this information is 
also critical for developing new treatments for GWI and related neurological 
dysfunction.
• Given the similarity of the health problems of GW veterans and those of other 
occupational groups with OP exposures (e.g., insecticide applicators, farmers, 
sheep dippers, nursery workers, chemical plant workers), the identification of 
treatments for the GW veteran population will have far-reaching implications for 
treating other groups of ill patients for whom no effective treatments have been 
identified.
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Table 2
Studies reporting on diagnosable neurological conditions in Gulf War veterans.
Study Groups studied Outcome(s) Key findings
Barth et al., 2009 621,902 GWV, 746,248 
NDV
Mortality due to brain cancer, MS, PD, 
and ALS
GWV potentially exposed to nerve agents 
over multiple days and GWV with greatest 
exposure to oil well fires had significantly 
higher rates of brain cancer mortality. 
Overall, mortality due to brain cancer, PD, 
MS, ALS similar in GWV and NDV.
Kang et al., 2009 6,111 GWV, 3,859 NDV Diagnosed medical conditions reported 
by veterans
Compared to NDV, GWV reported 
significantly higher rates of repeated seizures, 
neuralgia/neuritis, and stroke.
Kasarskis et al., 
2009
43 deployed GWV with 
ALS, 66 nondeployed 
GWV with ALS
ALS age of onset, site of onset, atypical 
symptom features, ventilator-free 
survival time
No differences between ALS symptoms, age 
and site of onset similar for deployed GWV 
versus nondeployed. Ventilator-free survival 
time post-diagnosis was significantly shorter 
in deployed GWV.
Wallin et al., 
2012
2,691 veterans who served 
in the military between 
1990 and 2007, and had 
applied for VA benefits for 
MS
MS incidence by age, sex, race and 
branch of service
No determination of MS rates specifically in 
relation to 1991 Gulf War era or deployment. 
MS incidence was significantly higher in 
females than males, blacks versus other races, 
and in Air Force and Army veterans versus 
other branches.
Rayhan, Raksit, 
et al., 2013; 
Rayhan, 
Ravindran, et al., 
2013; Rayhan, 
Stevens, et al., 
2013
50 symptomatic GWV, 39 
CFS patients, 45 sedentary 
controls
Structured headache evaluation Statistically similar proportions of GWV 
(64%) and CFS (82%) patients affected by 
migraines; both significantly greater than 
controls (13%).
Wallin et al., 
2014
387 GWV and 1,454 NDV 
who filed for disability 
benefits due to MS and 
ODD
MS incidence in GW-era veterans by 
age, sex, race and branch of service
MS incidence estimates (using entire active 
duty population of GWV and NDV as 
denominators), indicated no significant MS 
differences between GWV and NDV.
Abbreviations: GWV = Gulf War veterans; NDV = nondeployed veterans; ALS = amyotrophic lateral sclerosis; PD = Parkinson’s disease, MS = 
multiple sclerosis; CFS = chronic fatigue syndrome, ODD = other demyelinating disease.
(Table adapted from RACGWVI, 2014).
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Table 3
Studies reporting on psychiatric and psychological disorders in Gulf War veterans.
Study Groups studied Outcome(s) Key findings
Vogt et al., 2008 81 active duty GWV and 230 
NG/R GWV
DRRI, PTSS High PT and DLWE scores on the DRRI and PTSS were 
significantly stronger for active duty women and NG/R 
men.
Woodward et al., 
2009
50 PTSD+ (13 GWV and 37 VV) 
and 47 PTSD− (23 GWV and 24 
VV)
Cortical volume 
measured using MRI
Subjects with combat-related PTSD showed significantly 
smaller cerebral cortical volume, thickness and area 
compared to PTSD-controls.
Yehuda et al., 
2010
12 PTSD + GWV and 9 PTSD-
GWV
Plasma ACTH 
changes, declarative 
memory, MRI, PET, 
DST
PTSD + group showed significantly greater cortisol and 
ACTH suppression. Hippocampal volume difference and 
greater hippocampal metabolic activity seen in PTSD + 
GWV. No memory differences were seen.
Apfel et al., 2011 82 GWV with lifetime PTSD, 44 
GWV with current PTSD, 38 
GWV with MDD, 80 PTSD-
GWV
Hippocampal volume 
measured using MRI
GWV with chronic PTSD had smaller hippocampal 
volume than GWV without current PTSD. Current PTSD 
symptoms were associated with significantly reduced 
hippocampal volume.
Coughlin et al., 
2011
6,111 deployed GWV, 3,859 
nondeployed veterans
Alcohol use, PTSD, 
MDD
Problem drinking was significantly and positively 
associated with PTSD and MDD
Gade & Wenger, 
2011
1035 GWV, 3452 VV MCS Exposure to war casualties but not combat overall was 
associated with mental health decline. Negative effects 
of combat were larger for GWV compared to VV.
Hassija et al., 2012 87 GWV and 43 OIF/OEF 
veterans
PSS, DSS, alcohol 
misuse
Combat exposure was significantly associated with PSS, 
DSS and alcohol misuse.
Wachen et al., 
2013
317 GWV PSS, PCL, PHS Significant associations between post-deployment 
physical health and PSS in all symptom categories. PSS 
score was more strongly related to physical health for 
subjects with lower warzone exposures, but also 
significant for high warzone exposures.
Abbreviations: GWV = Gulf War veterans; MDD = major depressive disorder; PTSD = post-traumatic stress disorder; PTSD+ = meets the criteria 
for current PTSD resulting from one or more military trauma; PTSD− = did not meet criteria for PTSD, either current or lifetime; MRI = magnetic 
resonance imaging; MSI = multisymptom illness; MCS = Mental Component Summary; VV = Vietnam veterans; OEF = Operation Enduring 
Freedom; OIF = Operation Iraqi Freedom, PSS = post-traumatic stress disorder symptom severity; DSS = depressive symptom severity; PTSS = 
post-traumatic stress symptomatology; DRRI = Deployment Risk and Resilience Inventory; PT = perceived threat; DLWE = difficult living and 
working environment; NG/R = National Guard/Reserve; PCL = Post-traumatic Stress Disorder Checklist; PHS = physical health symptoms; ACTH 
= adrenocorticotropic hormone; PET = positron emission tomography; DST = dexamethasone suppression test.
(Table adapted from RACGWVI, 2014).
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Table 6
EEG and brain imaging findings in symptomatic Gulf War veterans.
Study Groups studied Method(s) Key findings
MRI and SPECT
Haley et al., 2009 21 GWV with Haley 
syndromes, 17 veteran 
controls
SPECT Syndrome 2 showed significantly lower resting nrCBF compared 
to controls and other syndrome groups. Reduction most apparent 
in caudate head, globus pallidus, putamen and posterior thalamus. 
Subjects with Syndrome 2 showed elevated nrCBF while other 
groups showed reduced nrCBF after physostigmine stimulation.
Weiner et al., 2011 81 symptomatic GWV, 101 
intermediate GWV, 97 
deployed veteran controls
MRI, MRS No significant differences in NAA and NAA metabolites in the 
basal ganglia and pons between symptomatic and control 
veterans.
Rayhan, Raksit, et 
al., 2013; Rayhan, 
Ravindran, et al., 
2013; Rayhan, 
Stevens, et al., 2013
15 symptomatic GWV, 11 
veteran and civilian controls
fMRI, MRS Prefrontal lactate levels prior to exercise predicted whether 
symptomatic GWV showed increased or decreased memory test 
scores.
Physostigmine challenge test
Li et al., 2011 35 GWV with Haley 
syndromes, 13 veteran 
controls
MRI-based ASL Abnormal hippocampal CBF persists in symptomatic GWV at 
baseline. Patients with Syndromes 2 and 3 showed significantly 
increased bilateral rCBF in hippocampi after physostigmine 
stimulation.
Liu et al., 2011 33 GWV with Haley 
syndromes, 14 
nonsymptomatic veteran 
controls
MRI-based ASL Expected physostigmine decrease in CBF was absent in 
symptomatic GWV, who showed either no change or increased 
CBF after cholinergic challenge. Physostigmine response 
differences between GWV and controls most pronounced in 
amygdala, hippocampus, caudate and thalamus.
Structural MRI
Calley et al., 2010 53 GWV with Haley 
syndromes, 16 
nonsymptomatic deployed 
GWV
fMRI Significant signal change increase in the thalamic region and 
signal change decrease in the caudate in Syndrome 2 subjects 
compared to Syndrome 1 and controls. Syndrome 2 subjects 
showed significantly positive association between reaction time 
on SORT task and percent signal change in bilateral caudate 
heads. Syndrome 1 and 3 subjects performed significantly worse 
on SORT compared to deployed controls.
Chao et al., 2011 64 GWV with suspected sarin 
or cyclosarin exposure 
matched to 64 unexposed 
GWV
MRI Sarin and cyclosarin exposed GWV showed significantly reduced 
total gray and white matter volumes compared to unexposed 
controls. GWI/CMI diagnosis significantly predicted gray and 
white matter volumes in sarin and cyclosarin exposed subjects. 
No dose–response relationships seen.
fMRI
Gopinath et al., 2012 40 GWV with Haley 
syndromes, 14 veteran 
controls
fMRI In response to innocuous heat, subjects with Syndromes 1 and 2 
showed significantly reduced activation in the insula, S1, S2, 
SMA, medial PPC, IPL, premotor cortex and DMPFC in 
compared to controls. Syndrome 1 and 2 exhibited significantly 
more activation to innocuous heat in the ventral anterior 
cingulate.
Hubbard et al., 2013 96 symptomatic GWV, 44 
matched controls
fMRI Significant differences were seen between groups for prefrontal 
cortex activity during a working memory task, indicating that 
GWVs allocate high demand working memory loads differently 
from controls.
Rayhan, Raksit, et 
al., 2013; Rayhan, 
Ravindran, et al., 
2013; Rayhan, 
Stevens, et al., 2013
28 symptomatic GWV, 10 
civilian controls
fMRI The GWI post-exercise orthostatic tachycardia subgroup showed 
brainstem atrophy and baseline working memory compensation in 
the vermis. The other GWI subgroup exhibited hyperalgesia in 
response to exercise, and had baseline working memory 
compensation in the basal ganglia when compared to controls. 
GWV showed impaired working memory compared to controls.
Rayhan, Raksit, et 
al., 2013; Rayhan, 
Ravindran, et al., 
31 GWV with CFS and CMI, 
12 sedentary control veterans
fMRI In GWV diagnosed with CMI or CFS, white matter integrity loss 
was identified in cortico-cortical and corticospinal areas. Changes 
in axial diffusivity in the IFOF significantly different between 
controls and CFS/CMI GWV.
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Study Groups studied Method(s) Key findings
2013; Rayhan, 
Stevens, et al., 2013
EEG
Tillman et al., 2012 20 GWV with Haley 
syndromes, 8 deployed 
asymptomatic GWV
ERP from EEG Haley syndrome group predicted P1 amplitude, P1 latency, with 
longer latencies in syndromes 2 and 3 compared to controls and 
Syndrome 1. Mean P3a amplitudes significantly different 
between syndromes 1 and 2 compared to controls and syndrome 
3.
Tillman et al., 2013 22 GWV with Haley 
syndromes, 8 deployed 
asymptomatic GWV
ERP from EEG Significantly lower P3b amplitudes in 3 syndrome groups 
compared to controls in an oddball attention task.
Abbreviations: GWV = Gulf War veterans; PTSD = post-traumatic stress disorder; SORT = Semantic object retrieval test; MRI = magnetic 
resonance imaging; fMRI = functional magnetic resonance imaging; GWI = Gulf War illness; CMI = chronic multisymptom illness; CSF = 
cerebrospinal fluid; S1 = Primary somatosensory cortex; S2 = Secondary somatosensory cortex; SMA = supplementary motor area; PPC = 
posterior parietal cortex; IPL = inferior parietal lobule; DMPFC = dorsomedial prefrontal cortex; SPECT = Single Photon Emission Computed 
Tomography; nrCBF = normalized regional cerebral blood flow; rCBF = regional cerebral blood flow; ASL = arterial spin labeling; CFS = chronic 
fatigue syndrome; IFOF = inferior fronto-occipital fasciculus; MRS = magnetic resonance spectroscopy; MS = multiple sclerosis; EEG = 
electroencephalogram; ERP = event related potential; NAA = N-acetyl aspartate; VV = Vietnam veterans; PHG = parahippocampal gyrus; STC = 
superior temporal cortex; OFC = orbital frontal cortex; PO = pars orbitalis.
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Table 7
Neurocognitive findings in Gulf War veterans.
Study Groups studied Key findings
Odegard et 
al., 2013
10 GWV Haley Syndrome 1; 
12 GWV Haley Syndrome 2; 
11 GWV Haley Syndrome 3; 
14 GWV well controls
Control GWV and GWV with Haley Syndrome 1 provided significantly more recall 
responses to face-name items than GWVs with Haley Syndrome 3. Memory performance 
was related to activation in the left hippocampus.
Tillman et 
al., 2010
25 GWV with major cognitive 
complaints; 23 matched GWV 
controls
The experimental group had significantly more false positives and significantly fewer hits 
than the control group suggesting inhibition difficulties. The mean P3 amplitude of the 
patient group was significantly lower than the control group, and also demonstrated a 
condition effect with decreased amplitude during the NOGO condition.
Toomey et 
al., 2009
1,061 deployed GWV; 1128 
nondeployed GWV
Eight factors were generated accounting for 68% of variance including verbal memory, 
attention/working memory, visual memory, executive functioning, perceptual motor speed, 
visual organization, motor speed, and sustained attention. With a cutoff of 2 SD below the 
mean the deployed group performed worse on motor speed and sustained attention. The 
deployed group performed significantly worse on Trails B compared to the nondeployed 
group. Self-reported exposure to contaminated food or water was a significant predictor of 
performance in sustained attention. Khamisiyah exposure was a significant predictor of 
verbal memory performance, CARC/paint and receipt of IG were significant predictors of 
visual memory performance, and SCUD missiles and vaccines of motor speed 
performance.
Wallin et al., 
2009
25 deployed GWV with CDC 
defined GWI; 16 deployed 
GWV without CDC defined 
GWI
No significant differences were found between GWI cases and controls in assessed 
cognitive domains. GWI cases and controls mean scores were both within normal limits 
compared to population based normative samples. GWI cases mean scores were all lower 
than controls. GWI cases were significantly more impaired on measures of mood and 
quality of life.
Abbreviations: GWV = Gulf War veteran; CARC = chemical agent resistant coating; IG = immunoglobulin; SD = standard deviation; CDC = 
Centers for Disease Control.
(Table adapted from RACGWVI, 2014).
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Table 8
Studies using animal and in Vitro models of Gulf War illness and related diseases.
Study Model Parameter(s) evaluated exposure Key findings
Abdullah et al., 
2011
Mouse PB, PER Exposed mice demonstrated significantly increased 
anxiety behavior, memory impairment and psychomotor 
dysfunction. After 150 days of exposure, significant 
increases in astrogliosis were seen in exposed mice. 
Proteomic analysis showed significant expression 
alterations for proteins that regulate lipid metabolism, 
molecular transport, and endocrine and immune 
function.
Abdullah et al., 
2012
Mouse PB, PER, DEET, stress Significant increases in ether-containing PC, diacyl, PC 
and SM lipids, indicating altered transport, uptake, 
storage and synthesis in ACh pathways in the brain. 
Anxiety-like behavior was increased in exposed mice, 
especially in females. Sensorimotor deficits were also 
significantly associated with exposure, as was 
astrogliosis.
Abdullah et al., 
2013
Mouse PB, PER Exposed mice had elevated brain levels of PC and SM 
phospholipid species, particularly those containing ether 
PC. Brain catalase staining was higher in exposed than 
control mice. Lyso-platelet activating factors 
(precursors of inflammatory lipid mediators) were 
decreased in the brain and blood from exposed 
compared to control mice.
Bozkurt et al., 
2010
Rat CPF Single CPF dose led to significant short term (12 h) 
changes in glial and neuronal markers in serum. 
Immediate significant changes in body weight and 
temperature persisted for approximately 168 h.
Cardona et al., 
2006
Rat CPF CPF significantly inhibited AChE and APF enzymatic 
activity even when signs of acute toxicity were absent. 
Striatum and brainstem areas showed slowed AChE 
recovery after CPF exposure.
Corbel et al., 
2009
Insect and mouse 
cultured tissue
DEET DEET application to insect CNS neuronal preparation 
produced significant initial increase in neuronal 
electrophysiological activation, followed by a 
significant decrease, indicating changes in synaptic 
transmission and inhibition of cholinesterase activity.
Grigoryan et al., 
2008
Bovine protein isolate Sarin, soman, CPO, DFP, FP-biotin Pesticide agents bind covalently to tubulin, a protein 
required for neuronal transport, putatively creating 
axonal transport deficits.
Grigoryan et al., 
2009
Bovine, human, porcine 
and murine protein 
isolate
FP-biotin OP esters bind to tyrosine in proteins across different 
species. OP-reactive proteins include enzymes with and 
without active serine sites.
Grigoryan et al., 
2009
Bovine, human, 
porcine, murine protein 
isolate
DFP, CPO OP esters covalently bind to lysine in albumin, keratin, 
actin, tubulin and transferrin in a number of mammalian 
species.
Jiang et al., 2010 Mouse CPF, CPO Microtubules isolated from brain tissue from exposed 
mice showed fewer associated proteins than control 
mice, and microtubules from exposed mice were 
significantly smaller in comparison to controls. Mice 
brains show CPO-labeled tubulin after injections of 
nontoxic doses of CPF or CPO.
Middlemore-
Risher et al., 
2011
Rat CPF, CPO Mitochondrial length, number and axonal movement 
were decreased in central nervous system neurons in 
rats exposed to CPF or CPO when compared to 
controls.
Nutter et al., 
2013
Rat CPF, PER, PB After exposure, K+ channel kinetics were altered in 
vascular pain receptors, with significant increases in 
electrophysiological excitability. No behavioral 
differences were noted between exposed and control 
animals, nor were significant effects seen in Na+ 
channel activity.
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Study Model Parameter(s) evaluated exposure Key findings
O’Callaghan et 
al., 2015
Mouse DFP, DEET, CORT Pretreatment with CORT greatly increased 
neuroinflammatory responses to DFP. Minocycline 
(anti-inflammatory) suppressed DFP + CORT 
neuroinflammation.
Ojo et al., 2013 Mouse CPF, PB, PER Exposure to CPF alone or in combination with PB and 
PER reduced synaptic function by reducing 
hippocampal synaptophysin and impairing cell 
differentiation in the dentate gyrus, with altered basal 
ACh levels throughout the brain.
Parihar et al., 
2013
Rat DEET, PER, PB, stress Exposure to low doses of DEET, PER and PB increased 
disordered mood and cognitive behaviors. Rats exposed 
to pesticides and stress showed significantly reduced 
hippocampal volume and neuron growth, and increased 
CNS inflammation.
Speed et al., 2012 Mouse CPF Mice injected with CPF showed a short term increase in 
synaptic transmission in the CA3–CA1 hippocampal 
region. After three months, decreased spine density in 
the hippocampus and reduced synaptic activity was 
seen in exposed versus control mice.
Torres-Altoro et 
al., 2011
Mouse CPF, sarin, PB, DEET, DFP CPF and PB altered dopaminergic and glutamatergic 
synaptic transmission in vivo and slice preparations. 
Combined PB/DEET/DFP exposure stimulated aberrant 
brain specific protein expression in the striatum and 
hippocampus.
Abbreviations: PB = pyridostigmine bromide; PER = permethrin; DEET = N,N-diethyl-meta-toluamide; PC = phosphatidylcholine; SM = 
sphingomyelin; ACh = acetylcholine; DU = depleted uranium; CPF = chlorpyrifos; CNS = central nervous system; CPO = chlorpyrifos oxon; DFP 
= diisopropylfluorophosphate; FP-biotin = 10-fluoroethoxyphosphinyl-N-biotinamidopentyldecanamide; OP = organophosphorus; AChE = 
acetylcholinesterase; APF = acylpeptide hydrolase; LV = left ventricular; TH = tyrosine hydroxylase; PC = phosphatidylcholine; SM = 
sphingomyelin; DU = depleted uranium; ROS = reactive oxygen species; CORT = corticosterone.
(Table adapted from RACGWVI, 2014).
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